PetMed Express Files 8-K on Financials

TL;DR

PETS filed an 8-K on June 11th detailing financial condition and operations.

AI Summary

PetMed Express, Inc. filed an 8-K on June 11, 2024, reporting on its results of operations and financial condition. The filing includes financial statements and exhibits related to the period ending June 11, 2024. The company, incorporated in Florida, operates as a drug store retailer.

Why It Matters

This filing provides investors with updated financial information and operational details for PetMed Express, Inc., crucial for assessing the company's current performance and future prospects.

Risk Assessment

Risk Level: low — This is a routine filing providing standard financial and operational updates without any immediate or significant disclosed risks.

Key Players & Entities

• PETMED EXPRESS INC (company) — Registrant
• June 11, 2024 (date) — Date of earliest event reported
• Florida (location) — State of incorporation
• 420 SOUTH CONGRESS AVENUE (address) — Principal executive offices
• Delray Beach (location) — City of principal executive offices

FAQ

Filing Documents

• pets-20240611.htm (8-K) — 28KB
• pets-2024331xex991.htm (EX-99.1) — 218KB
• 0001040130-24-000043.txt ( ) — 383KB
• pets-20240611.xsd (EX-101.SCH) — 2KB
• pets-20240611_lab.xml (EX-101.LAB) — 21KB
• pets-20240611_pre.xml (EX-101.PRE) — 12KB
• pets-20240611_htm.xml (XML) — 3KB

02 Results of Operations and Financial Condition

Item 2.02 Results of Operations and Financial Condition. On June 11, 2024, PetMed Express, Inc. (the "Company") issued a press release announcing its March 31, 2024 fourth quarter and fiscal year end financial results and other financial information, and that management would review these results in a conference call at 4:30 pm Eastern time on June 11, 2024. A copy of the press release is furnished herewith as Exhibit 99.1 and is incorporated herein by reference. The information in this Item 2.02 and the information contained in Exhibit 99.1 shall not be deemed "filed" for purposes of Section 18 of the Securities Exchange Act of 1934, as amended ("Exchange Act"), or otherwise subject to the liabilities of that section, and shall not be deemed incorporated by reference in any Company filing under the Securities Act of 1933, as amended ("Securities Act"), or the Exchange Act, whether made before or after the date hereof and regardless of any general incorporation language in such filings, except as shall be expressly set forth by specific reference in such filing. The Company is making reference to non-GAAP financial information in both the press release and the conference call. A reconciliation of these non-GAAP financial measures to the nearest comparable GAAP financial measures is contained in the attached press release.

01 Financial Statements and Exhibits

Item 9.01 Financial Statements and Exhibits. (d) Exhibits. 99.1 – Press release dated June 11, 2024. 104 – Cover Page Interactive Data File (formatted as Inline XBRL). EXHIBIT INDEX Exhibit No. Description 99.1 Press release dated June 11 , 202 4 104 Cover Page Interactive Data File (formatted as Inline XBRL) 2

SIGNATURES

SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. Dated: June 11, 2024 PETMED EXPRESS, INC. By: /s/ Christine Chambers Name: Christine Chambers Title: Chief Financial Officer, Treasurer and Secretary 3

View Full Filing

View this 8-K filing on SEC EDGAR